Veracyte Set to Join S&P SmallCap 600
Veracyte (NASD: VCYT) is set to join the S&P SmallCap 600 index effective prior to market opening on July 29, 2025. The company will replace Triumph Group (NYSE: TGI), which is being acquired by Warburg Pincus LLC and Berkshire Partners LLC.
The index change comes as Triumph Group's acquisition is expected to close soon, pending final conditions. Veracyte will be added to the Health Care sector of the index, while Triumph Group will be removed from the Industrials sector.
Veracyte (NASD: VCYT) entrer脿 a far parte dell'indice S&P SmallCap 600 a partire dall'apertura del mercato del 29 luglio 2025. La societ脿 sostituir脿 Triumph Group (NYSE: TGI), che sta per essere acquisita da Warburg Pincus LLC e Berkshire Partners LLC.
Il cambiamento nell'indice avviene poich茅 l'acquisizione di Triumph Group 猫 prevista in chiusura a breve, in attesa delle condizioni finali. Veracyte sar脿 inserita nel settore Sanit脿 dell'indice, mentre Triumph Group verr脿 rimosso dal settore Industriale.
Veracyte (NASD: VCYT) se incorporar谩 al 铆ndice S&P SmallCap 600 antes de la apertura del mercado el 29 de julio de 2025. La compa帽铆a reemplazar谩 a Triumph Group (NYSE: TGI), que est谩 siendo adquirida por Warburg Pincus LLC y Berkshire Partners LLC.
El cambio en el 铆ndice se produce ya que se espera que la adquisici贸n de Triumph Group se cierre pronto, pendiente de las condiciones finales. Veracyte se a帽adir谩 al sector de Salud del 铆ndice, mientras que Triumph Group ser谩 eliminado del sector Industrial.
Veracyte (NASD: VCYT)电� 2025雲� 7鞗� 29鞚� 鞁滌灔 臧滌灔 鞝勳棎 S&P SmallCap 600 歆�靾�鞐� 韼胳瀰霅� 鞓堨爼鞛呺媹雼�. 鞚� 須岇偓电� Warburg Pincus LLC鞕� Berkshire Partners LLC臧� 鞚胳垬 欷戩澑 Triumph Group (NYSE: TGI)毳� 雽�觳错暕雼堧嫟.
歆�靾� 氤�瓴届潃 Triumph Group鞚� 鞚胳垬臧� 斓滌 臁瓣贝鞚� 鞎炿憪瓿� 瓿� 毵堧毽悹 瓴冹溂搿� 鞓堨儊霅棎 霐半澕 鞚措（鞏挫雼堧嫟. Veracyte电� 歆�靾橃潣 項姢旒�鞏� 靹鬼劙鞐� 於旉皜霅橂┌, Triumph Group鞚� 靷办梾 靹鬼劙鞐愳劀 鞝滌櫢霅╇媹雼�.
Veracyte (NASD : VCYT) rejoindra l'indice S&P SmallCap 600 avant l'ouverture du march茅 le 29 juillet 2025. La soci茅t茅 remplacera Triumph Group (NYSE : TGI), qui est en cours d'acquisition par Warburg Pincus LLC et Berkshire Partners LLC.
Ce changement d'indice intervient alors que la cl么ture de l'acquisition de Triumph Group est imminente, sous r茅serve des conditions finales. Veracyte sera ajout茅e au secteur Sant茅 de l'indice, tandis que Triumph Group sera retir茅 du secteur Industrie.
Veracyte (NASD: VCYT) wird ab dem B枚rsenstart am 29. Juli 2025 in den S&P SmallCap 600 Index aufgenommen. Das Unternehmen ersetzt Triumph Group (NYSE: TGI), das von Warburg Pincus LLC und Berkshire Partners LLC 眉bernommen wird.
Die Index盲nderung erfolgt, da die 脺bernahme von Triumph Group kurz vor dem Abschluss steht, vorbehaltlich der endg眉ltigen Bedingungen. Veracyte wird dem Gesundheitssektor des Index hinzugef眉gt, w盲hrend Triumph Group aus dem Industriesektor entfernt wird.
- Inclusion in S&P SmallCap 600 index typically increases stock visibility and trading volume
- Addition to prominent index may lead to increased institutional investment due to index fund buying
- None.
Insights
Veracyte's addition to S&P SmallCap 600 likely drives institutional buying pressure and improved liquidity for shareholders.
Veracyte's inclusion in the S&P SmallCap 600 index represents a significant milestone with tangible benefits for shareholders. When companies join major indices, they experience what market professionals call the "index effect" - a phenomenon where passive funds tracking the index must purchase shares, creating temporary but meaningful buying pressure. For Veracyte, this translates to approximately
Beyond the short-term price action, index inclusion delivers three lasting benefits: enhanced trading liquidity as more institutions can now own the stock; increased analyst coverage as the company gains visibility; and potential valuation expansion as the stock becomes available to a broader investor base. The July 29 effective date gives investors and funds several days to position accordingly before the official rebalancing.
This development comes as Triumph Group exits the index through acquisition by private equity firms Warburg Pincus and Berkshire Partners. For healthcare investors, Veracyte's addition also increases the sector's weight within the SmallCap 600, replacing an industrial company and potentially driving incremental sector-specific fund flows.
Following is a summary of the changes that will take place prior to the open of trading on the effective date:
Effective Date | Index Name | Action | Company Name | Ticker | GICS听厂别肠迟辞谤 |
July 29, 2025 | S&P SmallCap 600 | Addition | Veracyte | VCYT | Health Care |
July 29, 2025 | S&P SmallCap 600 | Deletion | Triumph Group | TGI | Industrials |
For more information about S&P Dow Jones Indices, please visit .
ABOUT S&P DOW JONES INDICES
S&P Dow Jones Indices is the largest global resource for essential index-based concepts, data and research, and home to iconic financial market indicators, such as the S&P 500庐 and the Dow Jones Industrial Average庐. More assets are invested in products based on our indices than products based on indices from any other provider in the world. Since Charles Dow invented the first index in 1884, S&P DJI has been innovating and developing indices across the spectrum of asset classes helping to define the way investors measure and trade the markets.
S&P Dow Jones Indices is a division of S&P Global (NYSE: SPGI), which provides essential intelligence for individuals, companies, and governments to make decisions with confidence. For more information, visit .
FOR MORE INFORMATION:
S&P Dow Jones Indices
[email protected]
Media Inquiries
[email protected]
View original content:
SOURCE S&P Dow Jones Indices
FAQ
When will Veracyte (VCYT) join the S&P SmallCap 600 index?
Why is Veracyte (VCYT) replacing Triumph Group in the S&P SmallCap 600?
What sector will Veracyte (VCYT) be classified under in the S&P SmallCap 600?
What are the potential benefits for Veracyte (VCYT) joining the S&P SmallCap 600?
